StockData
Allurion Technologies, Inc. logo

Allurion Technologies, Inc. (ALUR) stock

ALURNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 15, 2026Score 4/30
$0.47+0.00 (0.00%)

Close on Oct 19, 2026Market cap $6.34MP/E –Yield –

Allurion Technologies, Inc. saw revenue fall 55.5% to $12.60M over the twelve months to Mar 31, 2026. At the latest close the market valued the company at $6.34M.

Revenue
$12.60M
-55.5% vs. a year earlier
Operating income
-$26.61M
TTM Q1 2026
EPS, diluted
-$3.86
TTM Q1 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Mar 31, 2026

Valuation

Market cap
$6.34M
P/E ratio
–
Price to sales
0.50
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$12.60M
Net income
-$33.35M
EPS, diluted
-$3.86
Book value per share
-$5.84
Diluted shares
13M

Trading

Previous close
$0.47
Open
$0.47
Day's range
$0.47 – $0.47
Volume
0
Average volume (20 days)
4,162

Market cap history

Month-end market cap since 2023, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodALURS&P 500DifferenceALUR per yearS&P 500 per year
1 month-54.8%+0.6%−55.4 pts
3 months-90.5%+3.4%−93.8 pts
Year to date-61.4%+13.3%−74.7 pts
1 year-76.1%+16.6%−92.7 pts
3 years-99.6%+86.4%−185.9 pts-83.7%+23.1%
5 years-99.8%+81.9%−181.7 pts-71.3%+12.7%

Five years at a glance

Fiscal years 2021 to 2025 and trailing twelve months, USD

Revenue

$12.60M-55.5% YoY

Gross profit

$6.64M-64.7% YoY

Operating income

-$26.61M

Net income

-$33.35M

EPS, diluted

-$3.86

Free cash flow

–
Reported periodTrailing twelve months

Press releases

Releases Allurion Technologies filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Allurion Technologies

Surgical & Medical Instruments & Apparatus

The provided excerpt consists exclusively of raw XBRL taxonomies, accounting identifiers, and financial schedule tags rather than descriptive business disclosures. As a result, the provided text does not contain factual information regarding the company's business activities, products, services, operating segments, or customer types.

Company profile, executives and history

Allurion Technologies stock: common questions

What is Allurion Technologies's stock price?

ALUR closed at $0.47 on Oct 19, 2026, up 0.00% on the day.

What is Allurion Technologies's market cap?

Allurion Technologies was worth $6.34M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is ALUR's P/E ratio?

Allurion Technologies lost money over the twelve months to Mar 31, 2026 (diluted EPS -$3.86), so it has no meaningful P/E ratio.

How much revenue does Allurion Technologies make?

Allurion Technologies reported revenue of $12.60M for the twelve months to Mar 31, 2026, down 55.5% from a year earlier.

Does Allurion Technologies pay a dividend?

No. Allurion Technologies has not paid a cash dividend over the last twelve months.

How has ALUR stock performed over the past year?

Including dividends, ALUR returned -76.1% over the past year, against +16.6% for the S&P 500.

Who are Allurion Technologies's competitors?

Companies most similar to Allurion Technologies by business, industry and size include PCT, RADX, AREB, VVOS, IVF.

See a number that looks wrong?